Vilarsh Healthcare Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 3.00 M
- Company Age 6 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.15 M
- Revenue Growth 4.44%
- Profit Growth -31.84%
- Ebitda -49.09%
- Net Worth 42.21%
- Total Assets 87.37%
About Vilarsh Healthcare
Vilarsh Healthcare Private Limited (VHPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 April 2018 (Six years and ten months 15 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 3.00 M.
The company currently has active open charges totaling ₹2.15 M.
Ruby Chaudhary and Vijay Solanki serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74999DL2018PTC332248
- Company No.
332248
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Apr 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Vilarsh Healthcare?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijay Solanki  | Director | 10-Apr-2018 | Current |
| Ruby Chaudhary | Director | 10-Apr-2018 | Current |
Financial Performance of Vilarsh Healthcare.
Vilarsh Healthcare Private Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 4.44% increase. The company also saw a substantial fall in profitability, with a 31.84% decrease in profit. The company's net worth Soared by an impressive increase of 42.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vilarsh Healthcare?
Unlock access to Vilarsh Healthcare's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Viovas Pharma Private LimitedVijay Solanki is a mutual person
Charges (Loans)
₹2.15 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.22 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Jun 2023 | Hdfc Bank Limited | ₹2.15 M | Open |
How Many Employees Work at Vilarsh Healthcare?
Unlock and access historical data on people associated with Vilarsh Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vilarsh Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vilarsh Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.